Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled, Phase 3b Clinical Trial in Patients with Moderate-to-Severe Genital Psoriasis

Main Article Content

Caitriona Ryan
Alan Menter
Lyn Guenther
Andrew Blauvelt
Robert Bissonnette
Fan E Yang
Allison P Bleakman
David A Amato

Keywords

genital psoriasis, ixekinumab, biologic therapy

Abstract

Abstract not Available.

 

Disclosures: Study sponsored by Eli Lilly.

 

Copyright 2018 SKIN